Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy.
Saved in:
| Title: | Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy. |
|---|---|
| Authors: | Nam, Jung Hyun1 (AUTHOR), Yeo, Chang Dong2 (AUTHOR), Park, Chan Kwon3 (AUTHOR), Kim, Sung Kyoung4 (AUTHOR), Kim, Ju Sang5 (AUTHOR), Kim, Yong Hyun6 (AUTHOR), Kim, Jin Woo7 (AUTHOR), Kim, Seung Joon1 (AUTHOR), Lee, Sang Haak2 (AUTHOR), Kang, Hye Seon6 (AUTHOR) beyer_kr@catholic.ac.kr |
| Source: | Thoracic Cancer. Sep2023, Vol. 14 Issue 26, p2657-2664. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17597706 |
|---|---|
| DOI: | 10.1111/1759-7714.15050 |
